5E Advanced Materials, Inc. — Form 10-Q Summary
Reporting period: Quarter and six months ended December 31, 2023, representing fiscal Q2 and first half of fiscal 2024. The filing is unaudited. The company is developing its Fort Cady boron and lithium project in California and reported no operating revenue.
Financial performance and position
Amounts below are in millions of U.S. dollars, except per-share data.
| Metric | Three months ended Dec. 31, 2023 | Six months ended Dec. 31, 2023 | Comparable 2022 period |
|---|---|---|---|
| Revenue | None | None | None |
| Operating expenses | $8.9 | $16.6 | $11.2 and $19.7, respectively |
| Operating loss | $8.9 | $16.6 | $11.2 and $19.7, respectively |
| Net loss | $10.6 | $20.0 | $14.9 and $10.3, respectively |
| Basic and diluted loss per share | $0.24 | $0.45 | $0.34 and $0.24, respectively |
| Cash used in operating activities | $14.8 for six months | $16.2 for six months | |
| Cash used in investing activities | $3.5 for six months | $16.1 for six months |
Gross margins are not applicable because the company had no revenue. For the six-month period, net loss increased by $9.7 million year over year, principally reflecting the absence of the prior-year $11.7 million derivative gain; operating loss improved by $3.1 million as expenses fell. The three-month net loss narrowed by $4.2 million versus 2022.
- Liquidity at Dec. 31, 2023: Cash and cash equivalents were $2.0 million, down from $20.3 million at June 30, 2023. Working capital was negative $5.5 million, versus positive $13.3 million.
- Debt: Gross debt was $63.7 million, including $63.6 million of convertible notes; reported long-term debt, net of unamortized discount and issuance costs, was $42.4 million. The notes are secured by substantially all company assets. Six-month net interest expense was $3.5 million; the stated effective rate on the notes was 22.5%.
- Capital investment: Construction in progress was $72.6 million, up from $67.6 million at June 30. Six-month construction-in-progress cash spending was $3.4 million.
Material changes and subsequent events
- Project expenses declined 57% for the six months, primarily because the prior-year period included more well plug-and-abandonment work. General and administrative expense rose 7%, as restructuring-related legal and professional fees more than offset lower compensation and share-based compensation costs.
- Investing cash use fell 78% year over year, reflecting reduced construction spending. Financing activities provided almost no cash in the first half of fiscal 2024, compared with $58.0 million in the comparable 2022 period, which included convertible-note proceeds.
- After the reporting date, stockholders approved an out-of-court restructuring. January equity closings issued shares at $1.025 per share; the MD&A reports approximately $17.75 million of proceeds, while separately stating $16.7 million of net proceeds. The amended notes mature August 15, 2028, convert at $1.5375 per share, and bear 4.5% interest if paid in cash or 10% if paid in additional notes. The minimum-cash covenant was waived through June 28, 2024 and reduced to $7.5 million thereafter.
- The restructuring materially dilutes shareholders: the filing says approximately 19.0 million shares were issued after quarter-end and that the amended notes are convertible into 66.3 million shares, including accrued interest paid in kind. Authorized common shares increased from 180 million to 360 million.
Outlook, risks and contingencies
- The company received final EPA authorization in November 2023 for initial boric-acid production under its underground injection control permit. It began wellfield operations in early January 2024 and expected small-scale facility production of boric acid and lithium carbonate by the end of calendar Q1 2024, subject to well conditioning, facility completion and commissioning. These are targets, not reported results.
- Management expects significant operating and development costs and says additional financing will be needed within 12 months. The filing concludes substantial doubt remains about the company’s ability to continue as a going concern. If cash falls below the $7.5 million covenant after June 28, 2024, an event of default could make the notes immediately payable; management says it could not repay without additional financing.
- Management says available funds and near-complete construction should support completion and commissioning of the small-scale facility, but further milestones—including operating it and advancing commercial-scale engineering and infrastructure—require capital.
- Purchase-order commitments were $5.1 million. A former construction contractor counterclaimed for approximately $5.5 million; the company disputes the claims, and it cannot estimate any reasonably possible loss.
- Other cited risks include project execution and production qualification, access to capital, inflation and construction costs, supply-chain delays, and the need for further UIC permit modifications for long-term operations.
Key facts for investors to verify
- Actual cash balance, cash burn and financing needs following the January restructuring, including whether the company can maintain the $7.5 million covenant.
- Production, commissioning and customer-qualification progress against the stated Q1 2024 target, and any subsequent EPA permit changes.
- Final accounting treatment and terms of the amended convertible notes, including interest accrual, conversion dilution and any corporate-event adjustments.
- Equity financing proceeds and share counts: the filing reports differing proceeds figures and inconsistent January 18 issuance quantities for 5ECAP (5,365,854 shares in one disclosure versus 5,635,854 in another).
- Outcome and potential financial exposure from the construction contractor litigation and the $5.1 million purchase commitments.